A 2021 study published in Obesity found that adding structured resistance training to GLP-1 receptor agonist treatment significantly attenuated lean mass loss compared to medication alone, with the exercise group preserving approximately 93 percent of their lean mass versus 78 percent in the medication-only group (Lundgren JR et al., Obesity, 2021, Designing a GLP-1 Cut for Bodybuilders If youre going to use compounded semaglutide or a similar medication during a cutting phase, the protocol needs to reflect your training goals, not just generic weight loss guidance
A selection of personalized product options will be provided based on your answers
The researchers found that the estimated mean change in hemoglobin A1c (HbA1c) after 40 weeks was 1.8, 1.5, and 0.1 percentage points for cagrilintide-semaglutide 2.4 mg each, 1.0 mg each, and placebo, respectively
[DOI] [PubMed] [Google Scholar] 13.Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Pilitsi E, et al